Fig. 3From: Safety, pharmacokinetics, metabolism and radiation dosimetry of 18F-tetrafluoroborate (18F-TFB) in healthy human subjectsCoronal PET/CT images of 18F-TFB in healthy male (a) and female (b) participants at 2 h post-injection. Physiologic distribution of 18F-TFB is seen in the thyroid, salivary glands, stomach, and intestines. Prominent excretion of radioactivity is seen in the urinary bladderBack to article page